美国FDA生物制品紫皮书数据库（U.S. FDA Purple Book: Database of Licensed Biological Products）- 药物在线

商品名	申请号	产品号	BLA类型	非专利名称	剂型	给药途径	规格/剂量	产品形式	批准日期	申请人	市场状态	许可证状态	参考产品非专利名称	参考产品专利名称
Eloctate	125487	005	351(a)	Antihemophilic Factor (Recombinant), Fc Fusion protein	For Injection	Intravenous	750IU	Single-Dose Vial	2014/06/06	Bioverativ Therapeutics, Inc.	Rx	Licensed		N/A
Eloctate	125487	006	351(a)	Antihemophilic Factor (Recombinant), Fc Fusion protein	For Injection	Intravenous	500IU	Single-Dose Vial	2014/06/06	Bioverativ Therapeutics, Inc.	Rx	Licensed		N/A
Eloctate	125487	007	351(a)	Antihemophilic Factor (Recombinant), Fc Fusion protein	For Injection	Intravenous	250IU	Single-Dose Vial	2014/06/06	Bioverativ Therapeutics, Inc.	Rx	Licensed		N/A
Evarrest	125392	003	351(a)	Fibrin Sealant Patch	Patch	Topical	55.5MG FIBRINOGEN&241.9IU THROMBIN/IN^2; 2x4 IN	Pouch	2014/05/27	Ethicon, Inc.	Rx	Licensed		N/A
Entyvio	125476	001	351(a)	vedolizumab	For Injection	Intravenous	300MG	Single-Dose Vial	2014/05/20	Takeda Pharmaceuticals U.S.A., Inc.	Rx	Licensed	N/A	N/A
Sylvant	125496	001	351(a)	siltuximab	For Injection	Intravenous	100MG	Single-Dose Vial	2014/04/23	Recordati Rare Diseases, Inc.	Rx	Licensed	N/A	N/A
Sylvant	125496	002	351(a)	siltuximab	For Injection	Intravenous	400MG	Single-Dose Vial	2014/04/23	Recordati Rare Diseases, Inc.	Rx	Licensed	N/A	N/A
Cyramza	125477	001	351(a)	ramucirumab	Injection	Intravenous	100MG/10ML (10MG/ML)	Single-Dose Vial	2014/04/21	Eli Lilly and Company	Rx	Licensed	N/A	N/A
Cyramza	125477	002	351(a)	ramucirumab	Injection	Intravenous	500MG/50ML (10MG/ML)	Single-Dose Vial	2014/04/21	Eli Lilly and Company	Rx	Licensed	N/A	N/A
Ragwitek	125478	001	351(a)	Short Ragweed Pollen Allergen Extract	Tablet	Sublingual	12 AMB A 1-UNITS/Tablet	Blister Pack	2014/04/17	ALK - Abello A/S	Rx	Licensed		N/A
Tanzeum	125431	001	351(a)	albiglutide	For Injection	Subcutaneous	30MG	Autoinjector	2014/04/15	GlaxoSmithKline LLC	Disc	Voluntarily Revoked	N/A	N/A
Tanzeum	125431	002	351(a)	albiglutide	For Injection	Subcutaneous	50MG	Autoinjector	2014/04/15	GlaxoSmithKline LLC	Disc	Voluntarily Revoked	N/A	N/A
Atryn	125284	002	351(a)	Antithrombin (Recombinant)	For Injection	Intravenous	525IU	Single-Dose Vial	2014/04/11	rEVO Biologics, Inc.	Disc	Voluntarily Revoked		N/A
Grastek	125473	001	351(a)	Timothy Grass Pollen Allergen Extract	Tablet	Sublingual	2800BAU/TABLET	Blister Pack	2014/04/11	ALK - Abello A/S	Rx	Licensed		N/A
Oralair	125471	001	351(a)	Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract	Tablet	Sublingual	300 IR TABS/CT	Blister Pack	2014/04/01	Stallergenes, SAS	Rx	Licensed		N/A
Alprolix	125444	001	351(a)	Coagulation Factor IX (Recombinant), Fc Fusion Protein	For Injection	Intravenous	500IU	Single-Dose Vial	2014/03/28	Bioverativ Therapeutics, Inc.	Rx	Licensed		N/A
Alprolix	125444	002	351(a)	Coagulation Factor IX (Recombinant), Fc Fusion Protein	For Injection	Intravenous	2000IU	Single-Dose Vial	2014/03/28	Bioverativ Therapeutics, Inc.	Rx	Licensed		N/A
Alprolix	125444	003	351(a)	Coagulation Factor IX (Recombinant), Fc Fusion Protein	For Injection	Intravenous	1000IU	Single-Dose Vial	2014/03/28	Bioverativ Therapeutics, Inc.	Rx	Licensed		N/A
Alprolix	125444	004	351(a)	Coagulation Factor IX (Recombinant), Fc Fusion Protein	For Injection	Intravenous	3000IU	Single-Dose Vial	2014/03/28	Bioverativ Therapeutics, Inc.	Rx	Licensed		N/A
Zenpep	022210	007	351(a)	pancrelipase	Capsule, Delayed Release	Oral	40,000USP UNITS; 126,000USP UNITS; 168,000USP UNITS		2014/03/25	Zenpep, LLC	Rx	Licensed	N/A	N/A

药品商品名或专利药名Proprietary (Brand) Name
药品通用名或非专利名称Nonproprietary (Proper) Name
药品申请号BLA Number
产品号Product Number
剂型Dosage Form
给药途径Route of Administration
产品形式Product Presentation
药品规格或剂量Strength
药品注册申请人Applicant
参考产品非专利名称Reference Product Proper Name
参考产品专利名称Reference Product Proprietary Name
BLA类型BLA Type
药品的市场状态Marketing Status
许可证号License Number
许可证状态Licensure
产品批准日期Approval Date	-